Hmdb loader
Record Information
Version5.0
StatusDetected but not Quantified
Creation Date2021-09-11 12:35:00 UTC
Update Date2021-09-26 23:07:09 UTC
HMDB IDHMDB0253734
Secondary Accession NumbersNone
Metabolite Identification
Common Name(R)-N-(2-(1H-Indol-3-yl)-1-(4-(4-methoxybenzyl)-5-phenethyl-4H-1,2,4-triazol-3-yl)ethyl)-2-aminoacetamide
Description(R)-N-(2-(1H-Indol-3-yl)-1-(4-(4-methoxybenzyl)-5-phenethyl-4H-1,2,4-triazol-3-yl)ethyl)-2-aminoacetamide belongs to the class of organic compounds known as 3-alkylindoles. 3-alkylindoles are compounds containing an indole moiety that carries an alkyl chain at the 3-position. Based on a literature review very few articles have been published on (R)-N-(2-(1H-Indol-3-yl)-1-(4-(4-methoxybenzyl)-5-phenethyl-4H-1,2,4-triazol-3-yl)ethyl)-2-aminoacetamide. This compound has been identified in human blood as reported by (PMID: 31557052 ). (r)-n-(2-(1h-indol-3-yl)-1-(4-(4-methoxybenzyl)-5-phenethyl-4h-1,2,4-triazol-3-yl)ethyl)-2-aminoacetamide is not a naturally occurring metabolite and is only found in those individuals exposed to this compound or its derivatives. Technically (R)-N-(2-(1H-Indol-3-yl)-1-(4-(4-methoxybenzyl)-5-phenethyl-4H-1,2,4-triazol-3-yl)ethyl)-2-aminoacetamide is part of the human exposome. The exposome can be defined as the collection of all the exposures of an individual in a lifetime and how those exposures relate to health. An individual's exposure begins before birth and includes insults from environmental and occupational sources.
Structure
Thumb
SynonymsNot Available
Chemical FormulaC30H32N6O2
Average Molecular Weight508.626
Monoisotopic Molecular Weight508.258674294
IUPAC Name2-amino-N-[2-(1H-indol-3-yl)-1-{4-[(4-methoxyphenyl)methyl]-5-(2-phenylethyl)-4H-1,2,4-triazol-3-yl}ethyl]acetamide
Traditional Name2-amino-N-[2-(1H-indol-3-yl)-1-{4-[(4-methoxyphenyl)methyl]-5-(2-phenylethyl)-1,2,4-triazol-3-yl}ethyl]acetamide
CAS Registry NumberNot Available
SMILES
COC1=CC=C(CN2C(CCC3=CC=CC=C3)=NN=C2C(CC2=CNC3=CC=CC=C23)NC(=O)CN)C=C1
InChI Identifier
InChI=1S/C30H32N6O2/c1-38-24-14-11-22(12-15-24)20-36-28(16-13-21-7-3-2-4-8-21)34-35-30(36)27(33-29(37)18-31)17-23-19-32-26-10-6-5-9-25(23)26/h2-12,14-15,19,27,32H,13,16-18,20,31H2,1H3,(H,33,37)
InChI KeyOZSZELOMMMKWTM-UHFFFAOYSA-N
Chemical Taxonomy
Description Belongs to the class of organic compounds known as 3-alkylindoles. 3-Alkylindoles are compounds containing an indole moiety that carries an alkyl chain at the 3-position.
KingdomOrganic compounds
Super ClassOrganoheterocyclic compounds
ClassIndoles and derivatives
Sub ClassIndoles
Direct Parent3-alkylindoles
Alternative Parents
Substituents
  • 3-alkylindole
  • Phenoxy compound
  • Anisole
  • Phenol ether
  • Methoxybenzene
  • Alkyl aryl ether
  • Monocyclic benzene moiety
  • Substituted pyrrole
  • Benzenoid
  • Azole
  • Heteroaromatic compound
  • Pyrrole
  • 1,2,4-triazole
  • Ether
  • Carboximidic acid derivative
  • Carboximidic acid
  • Azacycle
  • Organic 1,3-dipolar compound
  • Propargyl-type 1,3-dipolar organic compound
  • Organic oxygen compound
  • Primary amine
  • Amine
  • Organooxygen compound
  • Organonitrogen compound
  • Primary aliphatic amine
  • Hydrocarbon derivative
  • Organic nitrogen compound
  • Aromatic heteropolycyclic compound
Molecular FrameworkAromatic heteropolycyclic compounds
External DescriptorsNot Available
Ontology
Physiological effectNot Available
Disposition
ProcessNot Available
RoleNot Available
Physical Properties
StateNot Available
Experimental Molecular Properties
PropertyValueReference
Melting PointNot AvailableNot Available
Boiling PointNot AvailableNot Available
Water SolubilityNot AvailableNot Available
LogPNot AvailableNot Available
Experimental Chromatographic PropertiesNot Available
Predicted Molecular Properties
PropertyValueSource
logP3.65ALOGPS
logP3.5ChemAxon
logS-5.4ALOGPS
pKa (Strongest Acidic)12.55ChemAxon
pKa (Strongest Basic)8.14ChemAxon
Physiological Charge1ChemAxon
Hydrogen Acceptor Count5ChemAxon
Hydrogen Donor Count3ChemAxon
Polar Surface Area110.85 ŲChemAxon
Rotatable Bond Count11ChemAxon
Refractivity149.77 m³·mol⁻¹ChemAxon
Polarizability56.72 ųChemAxon
Number of Rings5ChemAxon
BioavailabilityNoChemAxon
Rule of FiveNoChemAxon
Ghose FilterNoChemAxon
Veber's RuleNoChemAxon
MDDR-like RuleYesChemAxon
Predicted Chromatographic Properties

Predicted Collision Cross Sections

PredictorAdduct TypeCCS Value (Å2)Reference
DeepCCS[M-2H]-245.13730932474
DeepCCS[M+Na]+220.56230932474

Predicted Retention Times

Underivatized

Chromatographic MethodRetention TimeReference
Predicted by Siyang on May 30, 202213.3515 minutes33406817
Predicted by Siyang using ReTip algorithm on June 8, 20223.2 minutes32390414
Fem_Long = Waters ACQUITY UPLC HSS T3 C18 with Water:MeOH and 0.1% Formic Acid2134.5 seconds40023050
Fem_Lipids = Ascentis Express C18 with (60:40 water:ACN):(90:10 IPA:ACN) and 10mM NH4COOH + 0.1% Formic Acid211.0 seconds40023050
Life_Old = Waters ACQUITY UPLC BEH C18 with Water:(20:80 acetone:ACN) and 0.1% Formic Acid220.3 seconds40023050
Life_New = RP Waters ACQUITY UPLC HSS T3 C18 with Water:(30:70 MeOH:ACN) and 0.1% Formic Acid183.3 seconds40023050
RIKEN = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid227.4 seconds40023050
Eawag_XBridgeC18 = XBridge C18 3.5u 2.1x50 mm with Water:MeOH and 0.1% Formic Acid478.7 seconds40023050
BfG_NTS_RP1 =Agilent Zorbax Eclipse Plus C18 (2.1 mm x 150 mm, 3.5 um) with Water:ACN and 0.1% Formic Acid441.7 seconds40023050
HILIC_BDD_2 = Merck SeQuant ZIC-HILIC with ACN(0.1% formic acid):water(16 mM ammonium formate)496.2 seconds40023050
UniToyama_Atlantis = RP Waters Atlantis T3 (2.1 x 150 mm, 5 um) with ACN:Water and 0.1% Formic Acid1156.6 seconds40023050
BDD_C18 = Hypersil Gold 1.9µm C18 with Water:ACN and 0.1% Formic Acid577.7 seconds40023050
UFZ_Phenomenex = Kinetex Core-Shell C18 2.6 um, 3.0 x 100 mm, Phenomenex with Water:MeOH and 0.1% Formic Acid1367.7 seconds40023050
SNU_RIKEN_POS = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid376.7 seconds40023050
RPMMFDA = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid353.2 seconds40023050
MTBLS87 = Merck SeQuant ZIC-pHILIC column with ACN:Water and :ammonium carbonate263.3 seconds40023050
KI_GIAR_zic_HILIC_pH2_7 = Merck SeQuant ZIC-HILIC with ACN:Water and 0.1% FA255.5 seconds40023050
Meister zic-pHILIC pH9.3 = Merck SeQuant ZIC-pHILIC column with ACN:Water 5mM NH4Ac pH9.3 and 5mM ammonium acetate in water10.9 seconds40023050

Predicted Kovats Retention Indices

Underivatized

MetaboliteSMILESKovats RI ValueColumn TypeReference
(R)-N-(2-(1H-Indol-3-yl)-1-(4-(4-methoxybenzyl)-5-phenethyl-4H-1,2,4-triazol-3-yl)ethyl)-2-aminoacetamideCOC1=CC=C(CN2C(CCC3=CC=CC=C3)=NN=C2C(CC2=CNC3=CC=CC=C23)NC(=O)CN)C=C15866.9Standard polar33892256
(R)-N-(2-(1H-Indol-3-yl)-1-(4-(4-methoxybenzyl)-5-phenethyl-4H-1,2,4-triazol-3-yl)ethyl)-2-aminoacetamideCOC1=CC=C(CN2C(CCC3=CC=CC=C3)=NN=C2C(CC2=CNC3=CC=CC=C23)NC(=O)CN)C=C14049.6Standard non polar33892256
(R)-N-(2-(1H-Indol-3-yl)-1-(4-(4-methoxybenzyl)-5-phenethyl-4H-1,2,4-triazol-3-yl)ethyl)-2-aminoacetamideCOC1=CC=C(CN2C(CCC3=CC=CC=C3)=NN=C2C(CC2=CNC3=CC=CC=C23)NC(=O)CN)C=C14826.8Semi standard non polar33892256

Derivatized

Derivative Name / StructureSMILESKovats RI ValueColumn TypeReference
(R)-N-(2-(1H-Indol-3-yl)-1-(4-(4-methoxybenzyl)-5-phenethyl-4H-1,2,4-triazol-3-yl)ethyl)-2-aminoacetamide,1TMS,isomer #1COC1=CC=C(CN2C(CCC3=CC=CC=C3)=NN=C2C(CC2=C[NH]C3=CC=CC=C23)NC(=O)CN[Si](C)(C)C)C=C14800.9Semi standard non polar33892256
(R)-N-(2-(1H-Indol-3-yl)-1-(4-(4-methoxybenzyl)-5-phenethyl-4H-1,2,4-triazol-3-yl)ethyl)-2-aminoacetamide,1TMS,isomer #1COC1=CC=C(CN2C(CCC3=CC=CC=C3)=NN=C2C(CC2=C[NH]C3=CC=CC=C23)NC(=O)CN[Si](C)(C)C)C=C14255.2Standard non polar33892256
(R)-N-(2-(1H-Indol-3-yl)-1-(4-(4-methoxybenzyl)-5-phenethyl-4H-1,2,4-triazol-3-yl)ethyl)-2-aminoacetamide,1TMS,isomer #1COC1=CC=C(CN2C(CCC3=CC=CC=C3)=NN=C2C(CC2=C[NH]C3=CC=CC=C23)NC(=O)CN[Si](C)(C)C)C=C16134.2Standard polar33892256
(R)-N-(2-(1H-Indol-3-yl)-1-(4-(4-methoxybenzyl)-5-phenethyl-4H-1,2,4-triazol-3-yl)ethyl)-2-aminoacetamide,1TMS,isomer #2COC1=CC=C(CN2C(CCC3=CC=CC=C3)=NN=C2C(CC2=CN([Si](C)(C)C)C3=CC=CC=C23)NC(=O)CN)C=C14840.6Semi standard non polar33892256
(R)-N-(2-(1H-Indol-3-yl)-1-(4-(4-methoxybenzyl)-5-phenethyl-4H-1,2,4-triazol-3-yl)ethyl)-2-aminoacetamide,1TMS,isomer #2COC1=CC=C(CN2C(CCC3=CC=CC=C3)=NN=C2C(CC2=CN([Si](C)(C)C)C3=CC=CC=C23)NC(=O)CN)C=C13995.7Standard non polar33892256
(R)-N-(2-(1H-Indol-3-yl)-1-(4-(4-methoxybenzyl)-5-phenethyl-4H-1,2,4-triazol-3-yl)ethyl)-2-aminoacetamide,1TMS,isomer #2COC1=CC=C(CN2C(CCC3=CC=CC=C3)=NN=C2C(CC2=CN([Si](C)(C)C)C3=CC=CC=C23)NC(=O)CN)C=C16487.4Standard polar33892256
(R)-N-(2-(1H-Indol-3-yl)-1-(4-(4-methoxybenzyl)-5-phenethyl-4H-1,2,4-triazol-3-yl)ethyl)-2-aminoacetamide,1TMS,isomer #3COC1=CC=C(CN2C(CCC3=CC=CC=C3)=NN=C2C(CC2=C[NH]C3=CC=CC=C23)N(C(=O)CN)[Si](C)(C)C)C=C14647.5Semi standard non polar33892256
(R)-N-(2-(1H-Indol-3-yl)-1-(4-(4-methoxybenzyl)-5-phenethyl-4H-1,2,4-triazol-3-yl)ethyl)-2-aminoacetamide,1TMS,isomer #3COC1=CC=C(CN2C(CCC3=CC=CC=C3)=NN=C2C(CC2=C[NH]C3=CC=CC=C23)N(C(=O)CN)[Si](C)(C)C)C=C14104.3Standard non polar33892256
(R)-N-(2-(1H-Indol-3-yl)-1-(4-(4-methoxybenzyl)-5-phenethyl-4H-1,2,4-triazol-3-yl)ethyl)-2-aminoacetamide,1TMS,isomer #3COC1=CC=C(CN2C(CCC3=CC=CC=C3)=NN=C2C(CC2=C[NH]C3=CC=CC=C23)N(C(=O)CN)[Si](C)(C)C)C=C16328.7Standard polar33892256
(R)-N-(2-(1H-Indol-3-yl)-1-(4-(4-methoxybenzyl)-5-phenethyl-4H-1,2,4-triazol-3-yl)ethyl)-2-aminoacetamide,2TMS,isomer #1COC1=CC=C(CN2C(CCC3=CC=CC=C3)=NN=C2C(CC2=CN([Si](C)(C)C)C3=CC=CC=C23)NC(=O)CN[Si](C)(C)C)C=C14781.8Semi standard non polar33892256
(R)-N-(2-(1H-Indol-3-yl)-1-(4-(4-methoxybenzyl)-5-phenethyl-4H-1,2,4-triazol-3-yl)ethyl)-2-aminoacetamide,2TMS,isomer #1COC1=CC=C(CN2C(CCC3=CC=CC=C3)=NN=C2C(CC2=CN([Si](C)(C)C)C3=CC=CC=C23)NC(=O)CN[Si](C)(C)C)C=C14113.1Standard non polar33892256
(R)-N-(2-(1H-Indol-3-yl)-1-(4-(4-methoxybenzyl)-5-phenethyl-4H-1,2,4-triazol-3-yl)ethyl)-2-aminoacetamide,2TMS,isomer #1COC1=CC=C(CN2C(CCC3=CC=CC=C3)=NN=C2C(CC2=CN([Si](C)(C)C)C3=CC=CC=C23)NC(=O)CN[Si](C)(C)C)C=C15757.9Standard polar33892256
(R)-N-(2-(1H-Indol-3-yl)-1-(4-(4-methoxybenzyl)-5-phenethyl-4H-1,2,4-triazol-3-yl)ethyl)-2-aminoacetamide,2TMS,isomer #2COC1=CC=C(CN2C(CCC3=CC=CC=C3)=NN=C2C(CC2=C[NH]C3=CC=CC=C23)N(C(=O)CN[Si](C)(C)C)[Si](C)(C)C)C=C14659.9Semi standard non polar33892256
(R)-N-(2-(1H-Indol-3-yl)-1-(4-(4-methoxybenzyl)-5-phenethyl-4H-1,2,4-triazol-3-yl)ethyl)-2-aminoacetamide,2TMS,isomer #2COC1=CC=C(CN2C(CCC3=CC=CC=C3)=NN=C2C(CC2=C[NH]C3=CC=CC=C23)N(C(=O)CN[Si](C)(C)C)[Si](C)(C)C)C=C14226.8Standard non polar33892256
(R)-N-(2-(1H-Indol-3-yl)-1-(4-(4-methoxybenzyl)-5-phenethyl-4H-1,2,4-triazol-3-yl)ethyl)-2-aminoacetamide,2TMS,isomer #2COC1=CC=C(CN2C(CCC3=CC=CC=C3)=NN=C2C(CC2=C[NH]C3=CC=CC=C23)N(C(=O)CN[Si](C)(C)C)[Si](C)(C)C)C=C15778.2Standard polar33892256
(R)-N-(2-(1H-Indol-3-yl)-1-(4-(4-methoxybenzyl)-5-phenethyl-4H-1,2,4-triazol-3-yl)ethyl)-2-aminoacetamide,2TMS,isomer #3COC1=CC=C(CN2C(CCC3=CC=CC=C3)=NN=C2C(CC2=C[NH]C3=CC=CC=C23)NC(=O)CN([Si](C)(C)C)[Si](C)(C)C)C=C14828.0Semi standard non polar33892256
(R)-N-(2-(1H-Indol-3-yl)-1-(4-(4-methoxybenzyl)-5-phenethyl-4H-1,2,4-triazol-3-yl)ethyl)-2-aminoacetamide,2TMS,isomer #3COC1=CC=C(CN2C(CCC3=CC=CC=C3)=NN=C2C(CC2=C[NH]C3=CC=CC=C23)NC(=O)CN([Si](C)(C)C)[Si](C)(C)C)C=C14315.9Standard non polar33892256
(R)-N-(2-(1H-Indol-3-yl)-1-(4-(4-methoxybenzyl)-5-phenethyl-4H-1,2,4-triazol-3-yl)ethyl)-2-aminoacetamide,2TMS,isomer #3COC1=CC=C(CN2C(CCC3=CC=CC=C3)=NN=C2C(CC2=C[NH]C3=CC=CC=C23)NC(=O)CN([Si](C)(C)C)[Si](C)(C)C)C=C15845.4Standard polar33892256
(R)-N-(2-(1H-Indol-3-yl)-1-(4-(4-methoxybenzyl)-5-phenethyl-4H-1,2,4-triazol-3-yl)ethyl)-2-aminoacetamide,2TMS,isomer #4COC1=CC=C(CN2C(CCC3=CC=CC=C3)=NN=C2C(CC2=CN([Si](C)(C)C)C3=CC=CC=C23)N(C(=O)CN)[Si](C)(C)C)C=C14639.4Semi standard non polar33892256
(R)-N-(2-(1H-Indol-3-yl)-1-(4-(4-methoxybenzyl)-5-phenethyl-4H-1,2,4-triazol-3-yl)ethyl)-2-aminoacetamide,2TMS,isomer #4COC1=CC=C(CN2C(CCC3=CC=CC=C3)=NN=C2C(CC2=CN([Si](C)(C)C)C3=CC=CC=C23)N(C(=O)CN)[Si](C)(C)C)C=C13987.3Standard non polar33892256
(R)-N-(2-(1H-Indol-3-yl)-1-(4-(4-methoxybenzyl)-5-phenethyl-4H-1,2,4-triazol-3-yl)ethyl)-2-aminoacetamide,2TMS,isomer #4COC1=CC=C(CN2C(CCC3=CC=CC=C3)=NN=C2C(CC2=CN([Si](C)(C)C)C3=CC=CC=C23)N(C(=O)CN)[Si](C)(C)C)C=C15939.5Standard polar33892256
(R)-N-(2-(1H-Indol-3-yl)-1-(4-(4-methoxybenzyl)-5-phenethyl-4H-1,2,4-triazol-3-yl)ethyl)-2-aminoacetamide,3TMS,isomer #1COC1=CC=C(CN2C(CCC3=CC=CC=C3)=NN=C2C(CC2=CN([Si](C)(C)C)C3=CC=CC=C23)N(C(=O)CN[Si](C)(C)C)[Si](C)(C)C)C=C14641.0Semi standard non polar33892256
(R)-N-(2-(1H-Indol-3-yl)-1-(4-(4-methoxybenzyl)-5-phenethyl-4H-1,2,4-triazol-3-yl)ethyl)-2-aminoacetamide,3TMS,isomer #1COC1=CC=C(CN2C(CCC3=CC=CC=C3)=NN=C2C(CC2=CN([Si](C)(C)C)C3=CC=CC=C23)N(C(=O)CN[Si](C)(C)C)[Si](C)(C)C)C=C14088.2Standard non polar33892256
(R)-N-(2-(1H-Indol-3-yl)-1-(4-(4-methoxybenzyl)-5-phenethyl-4H-1,2,4-triazol-3-yl)ethyl)-2-aminoacetamide,3TMS,isomer #1COC1=CC=C(CN2C(CCC3=CC=CC=C3)=NN=C2C(CC2=CN([Si](C)(C)C)C3=CC=CC=C23)N(C(=O)CN[Si](C)(C)C)[Si](C)(C)C)C=C15471.1Standard polar33892256
(R)-N-(2-(1H-Indol-3-yl)-1-(4-(4-methoxybenzyl)-5-phenethyl-4H-1,2,4-triazol-3-yl)ethyl)-2-aminoacetamide,3TMS,isomer #2COC1=CC=C(CN2C(CCC3=CC=CC=C3)=NN=C2C(CC2=CN([Si](C)(C)C)C3=CC=CC=C23)NC(=O)CN([Si](C)(C)C)[Si](C)(C)C)C=C14828.4Semi standard non polar33892256
(R)-N-(2-(1H-Indol-3-yl)-1-(4-(4-methoxybenzyl)-5-phenethyl-4H-1,2,4-triazol-3-yl)ethyl)-2-aminoacetamide,3TMS,isomer #2COC1=CC=C(CN2C(CCC3=CC=CC=C3)=NN=C2C(CC2=CN([Si](C)(C)C)C3=CC=CC=C23)NC(=O)CN([Si](C)(C)C)[Si](C)(C)C)C=C14164.5Standard non polar33892256
(R)-N-(2-(1H-Indol-3-yl)-1-(4-(4-methoxybenzyl)-5-phenethyl-4H-1,2,4-triazol-3-yl)ethyl)-2-aminoacetamide,3TMS,isomer #2COC1=CC=C(CN2C(CCC3=CC=CC=C3)=NN=C2C(CC2=CN([Si](C)(C)C)C3=CC=CC=C23)NC(=O)CN([Si](C)(C)C)[Si](C)(C)C)C=C15533.2Standard polar33892256
(R)-N-(2-(1H-Indol-3-yl)-1-(4-(4-methoxybenzyl)-5-phenethyl-4H-1,2,4-triazol-3-yl)ethyl)-2-aminoacetamide,3TMS,isomer #3COC1=CC=C(CN2C(CCC3=CC=CC=C3)=NN=C2C(CC2=C[NH]C3=CC=CC=C23)N(C(=O)CN([Si](C)(C)C)[Si](C)(C)C)[Si](C)(C)C)C=C14742.0Semi standard non polar33892256
(R)-N-(2-(1H-Indol-3-yl)-1-(4-(4-methoxybenzyl)-5-phenethyl-4H-1,2,4-triazol-3-yl)ethyl)-2-aminoacetamide,3TMS,isomer #3COC1=CC=C(CN2C(CCC3=CC=CC=C3)=NN=C2C(CC2=C[NH]C3=CC=CC=C23)N(C(=O)CN([Si](C)(C)C)[Si](C)(C)C)[Si](C)(C)C)C=C14258.1Standard non polar33892256
(R)-N-(2-(1H-Indol-3-yl)-1-(4-(4-methoxybenzyl)-5-phenethyl-4H-1,2,4-triazol-3-yl)ethyl)-2-aminoacetamide,3TMS,isomer #3COC1=CC=C(CN2C(CCC3=CC=CC=C3)=NN=C2C(CC2=C[NH]C3=CC=CC=C23)N(C(=O)CN([Si](C)(C)C)[Si](C)(C)C)[Si](C)(C)C)C=C15523.1Standard polar33892256
(R)-N-(2-(1H-Indol-3-yl)-1-(4-(4-methoxybenzyl)-5-phenethyl-4H-1,2,4-triazol-3-yl)ethyl)-2-aminoacetamide,4TMS,isomer #1COC1=CC=C(CN2C(CCC3=CC=CC=C3)=NN=C2C(CC2=CN([Si](C)(C)C)C3=CC=CC=C23)N(C(=O)CN([Si](C)(C)C)[Si](C)(C)C)[Si](C)(C)C)C=C14762.3Semi standard non polar33892256
(R)-N-(2-(1H-Indol-3-yl)-1-(4-(4-methoxybenzyl)-5-phenethyl-4H-1,2,4-triazol-3-yl)ethyl)-2-aminoacetamide,4TMS,isomer #1COC1=CC=C(CN2C(CCC3=CC=CC=C3)=NN=C2C(CC2=CN([Si](C)(C)C)C3=CC=CC=C23)N(C(=O)CN([Si](C)(C)C)[Si](C)(C)C)[Si](C)(C)C)C=C14158.6Standard non polar33892256
(R)-N-(2-(1H-Indol-3-yl)-1-(4-(4-methoxybenzyl)-5-phenethyl-4H-1,2,4-triazol-3-yl)ethyl)-2-aminoacetamide,4TMS,isomer #1COC1=CC=C(CN2C(CCC3=CC=CC=C3)=NN=C2C(CC2=CN([Si](C)(C)C)C3=CC=CC=C23)N(C(=O)CN([Si](C)(C)C)[Si](C)(C)C)[Si](C)(C)C)C=C15280.0Standard polar33892256
(R)-N-(2-(1H-Indol-3-yl)-1-(4-(4-methoxybenzyl)-5-phenethyl-4H-1,2,4-triazol-3-yl)ethyl)-2-aminoacetamide,1TBDMS,isomer #1COC1=CC=C(CN2C(CCC3=CC=CC=C3)=NN=C2C(CC2=C[NH]C3=CC=CC=C23)NC(=O)CN[Si](C)(C)C(C)(C)C)C=C15002.0Semi standard non polar33892256
(R)-N-(2-(1H-Indol-3-yl)-1-(4-(4-methoxybenzyl)-5-phenethyl-4H-1,2,4-triazol-3-yl)ethyl)-2-aminoacetamide,1TBDMS,isomer #1COC1=CC=C(CN2C(CCC3=CC=CC=C3)=NN=C2C(CC2=C[NH]C3=CC=CC=C23)NC(=O)CN[Si](C)(C)C(C)(C)C)C=C14406.4Standard non polar33892256
(R)-N-(2-(1H-Indol-3-yl)-1-(4-(4-methoxybenzyl)-5-phenethyl-4H-1,2,4-triazol-3-yl)ethyl)-2-aminoacetamide,1TBDMS,isomer #1COC1=CC=C(CN2C(CCC3=CC=CC=C3)=NN=C2C(CC2=C[NH]C3=CC=CC=C23)NC(=O)CN[Si](C)(C)C(C)(C)C)C=C16100.1Standard polar33892256
(R)-N-(2-(1H-Indol-3-yl)-1-(4-(4-methoxybenzyl)-5-phenethyl-4H-1,2,4-triazol-3-yl)ethyl)-2-aminoacetamide,1TBDMS,isomer #2COC1=CC=C(CN2C(CCC3=CC=CC=C3)=NN=C2C(CC2=CN([Si](C)(C)C(C)(C)C)C3=CC=CC=C23)NC(=O)CN)C=C15032.9Semi standard non polar33892256
(R)-N-(2-(1H-Indol-3-yl)-1-(4-(4-methoxybenzyl)-5-phenethyl-4H-1,2,4-triazol-3-yl)ethyl)-2-aminoacetamide,1TBDMS,isomer #2COC1=CC=C(CN2C(CCC3=CC=CC=C3)=NN=C2C(CC2=CN([Si](C)(C)C(C)(C)C)C3=CC=CC=C23)NC(=O)CN)C=C14129.6Standard non polar33892256
(R)-N-(2-(1H-Indol-3-yl)-1-(4-(4-methoxybenzyl)-5-phenethyl-4H-1,2,4-triazol-3-yl)ethyl)-2-aminoacetamide,1TBDMS,isomer #2COC1=CC=C(CN2C(CCC3=CC=CC=C3)=NN=C2C(CC2=CN([Si](C)(C)C(C)(C)C)C3=CC=CC=C23)NC(=O)CN)C=C16407.7Standard polar33892256
(R)-N-(2-(1H-Indol-3-yl)-1-(4-(4-methoxybenzyl)-5-phenethyl-4H-1,2,4-triazol-3-yl)ethyl)-2-aminoacetamide,1TBDMS,isomer #3COC1=CC=C(CN2C(CCC3=CC=CC=C3)=NN=C2C(CC2=C[NH]C3=CC=CC=C23)N(C(=O)CN)[Si](C)(C)C(C)(C)C)C=C14859.2Semi standard non polar33892256
(R)-N-(2-(1H-Indol-3-yl)-1-(4-(4-methoxybenzyl)-5-phenethyl-4H-1,2,4-triazol-3-yl)ethyl)-2-aminoacetamide,1TBDMS,isomer #3COC1=CC=C(CN2C(CCC3=CC=CC=C3)=NN=C2C(CC2=C[NH]C3=CC=CC=C23)N(C(=O)CN)[Si](C)(C)C(C)(C)C)C=C14274.7Standard non polar33892256
(R)-N-(2-(1H-Indol-3-yl)-1-(4-(4-methoxybenzyl)-5-phenethyl-4H-1,2,4-triazol-3-yl)ethyl)-2-aminoacetamide,1TBDMS,isomer #3COC1=CC=C(CN2C(CCC3=CC=CC=C3)=NN=C2C(CC2=C[NH]C3=CC=CC=C23)N(C(=O)CN)[Si](C)(C)C(C)(C)C)C=C16253.0Standard polar33892256
(R)-N-(2-(1H-Indol-3-yl)-1-(4-(4-methoxybenzyl)-5-phenethyl-4H-1,2,4-triazol-3-yl)ethyl)-2-aminoacetamide,2TBDMS,isomer #1COC1=CC=C(CN2C(CCC3=CC=CC=C3)=NN=C2C(CC2=CN([Si](C)(C)C(C)(C)C)C3=CC=CC=C23)NC(=O)CN[Si](C)(C)C(C)(C)C)C=C15121.8Semi standard non polar33892256
(R)-N-(2-(1H-Indol-3-yl)-1-(4-(4-methoxybenzyl)-5-phenethyl-4H-1,2,4-triazol-3-yl)ethyl)-2-aminoacetamide,2TBDMS,isomer #1COC1=CC=C(CN2C(CCC3=CC=CC=C3)=NN=C2C(CC2=CN([Si](C)(C)C(C)(C)C)C3=CC=CC=C23)NC(=O)CN[Si](C)(C)C(C)(C)C)C=C14370.1Standard non polar33892256
(R)-N-(2-(1H-Indol-3-yl)-1-(4-(4-methoxybenzyl)-5-phenethyl-4H-1,2,4-triazol-3-yl)ethyl)-2-aminoacetamide,2TBDMS,isomer #1COC1=CC=C(CN2C(CCC3=CC=CC=C3)=NN=C2C(CC2=CN([Si](C)(C)C(C)(C)C)C3=CC=CC=C23)NC(=O)CN[Si](C)(C)C(C)(C)C)C=C15760.8Standard polar33892256
(R)-N-(2-(1H-Indol-3-yl)-1-(4-(4-methoxybenzyl)-5-phenethyl-4H-1,2,4-triazol-3-yl)ethyl)-2-aminoacetamide,2TBDMS,isomer #2COC1=CC=C(CN2C(CCC3=CC=CC=C3)=NN=C2C(CC2=C[NH]C3=CC=CC=C23)N(C(=O)CN[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C=C15047.4Semi standard non polar33892256
(R)-N-(2-(1H-Indol-3-yl)-1-(4-(4-methoxybenzyl)-5-phenethyl-4H-1,2,4-triazol-3-yl)ethyl)-2-aminoacetamide,2TBDMS,isomer #2COC1=CC=C(CN2C(CCC3=CC=CC=C3)=NN=C2C(CC2=C[NH]C3=CC=CC=C23)N(C(=O)CN[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C=C14513.4Standard non polar33892256
(R)-N-(2-(1H-Indol-3-yl)-1-(4-(4-methoxybenzyl)-5-phenethyl-4H-1,2,4-triazol-3-yl)ethyl)-2-aminoacetamide,2TBDMS,isomer #2COC1=CC=C(CN2C(CCC3=CC=CC=C3)=NN=C2C(CC2=C[NH]C3=CC=CC=C23)N(C(=O)CN[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C=C15750.3Standard polar33892256
(R)-N-(2-(1H-Indol-3-yl)-1-(4-(4-methoxybenzyl)-5-phenethyl-4H-1,2,4-triazol-3-yl)ethyl)-2-aminoacetamide,2TBDMS,isomer #3COC1=CC=C(CN2C(CCC3=CC=CC=C3)=NN=C2C(CC2=C[NH]C3=CC=CC=C23)NC(=O)CN([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C=C15252.7Semi standard non polar33892256
(R)-N-(2-(1H-Indol-3-yl)-1-(4-(4-methoxybenzyl)-5-phenethyl-4H-1,2,4-triazol-3-yl)ethyl)-2-aminoacetamide,2TBDMS,isomer #3COC1=CC=C(CN2C(CCC3=CC=CC=C3)=NN=C2C(CC2=C[NH]C3=CC=CC=C23)NC(=O)CN([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C=C14544.0Standard non polar33892256
(R)-N-(2-(1H-Indol-3-yl)-1-(4-(4-methoxybenzyl)-5-phenethyl-4H-1,2,4-triazol-3-yl)ethyl)-2-aminoacetamide,2TBDMS,isomer #3COC1=CC=C(CN2C(CCC3=CC=CC=C3)=NN=C2C(CC2=C[NH]C3=CC=CC=C23)NC(=O)CN([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C=C15784.5Standard polar33892256
(R)-N-(2-(1H-Indol-3-yl)-1-(4-(4-methoxybenzyl)-5-phenethyl-4H-1,2,4-triazol-3-yl)ethyl)-2-aminoacetamide,2TBDMS,isomer #4COC1=CC=C(CN2C(CCC3=CC=CC=C3)=NN=C2C(CC2=CN([Si](C)(C)C(C)(C)C)C3=CC=CC=C23)N(C(=O)CN)[Si](C)(C)C(C)(C)C)C=C14989.3Semi standard non polar33892256
(R)-N-(2-(1H-Indol-3-yl)-1-(4-(4-methoxybenzyl)-5-phenethyl-4H-1,2,4-triazol-3-yl)ethyl)-2-aminoacetamide,2TBDMS,isomer #4COC1=CC=C(CN2C(CCC3=CC=CC=C3)=NN=C2C(CC2=CN([Si](C)(C)C(C)(C)C)C3=CC=CC=C23)N(C(=O)CN)[Si](C)(C)C(C)(C)C)C=C14255.5Standard non polar33892256
(R)-N-(2-(1H-Indol-3-yl)-1-(4-(4-methoxybenzyl)-5-phenethyl-4H-1,2,4-triazol-3-yl)ethyl)-2-aminoacetamide,2TBDMS,isomer #4COC1=CC=C(CN2C(CCC3=CC=CC=C3)=NN=C2C(CC2=CN([Si](C)(C)C(C)(C)C)C3=CC=CC=C23)N(C(=O)CN)[Si](C)(C)C(C)(C)C)C=C15889.1Standard polar33892256
(R)-N-(2-(1H-Indol-3-yl)-1-(4-(4-methoxybenzyl)-5-phenethyl-4H-1,2,4-triazol-3-yl)ethyl)-2-aminoacetamide,3TBDMS,isomer #1COC1=CC=C(CN2C(CCC3=CC=CC=C3)=NN=C2C(CC2=CN([Si](C)(C)C(C)(C)C)C3=CC=CC=C23)N(C(=O)CN[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C=C15149.9Semi standard non polar33892256
(R)-N-(2-(1H-Indol-3-yl)-1-(4-(4-methoxybenzyl)-5-phenethyl-4H-1,2,4-triazol-3-yl)ethyl)-2-aminoacetamide,3TBDMS,isomer #1COC1=CC=C(CN2C(CCC3=CC=CC=C3)=NN=C2C(CC2=CN([Si](C)(C)C(C)(C)C)C3=CC=CC=C23)N(C(=O)CN[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C=C14510.2Standard non polar33892256
(R)-N-(2-(1H-Indol-3-yl)-1-(4-(4-methoxybenzyl)-5-phenethyl-4H-1,2,4-triazol-3-yl)ethyl)-2-aminoacetamide,3TBDMS,isomer #1COC1=CC=C(CN2C(CCC3=CC=CC=C3)=NN=C2C(CC2=CN([Si](C)(C)C(C)(C)C)C3=CC=CC=C23)N(C(=O)CN[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C=C15509.5Standard polar33892256
(R)-N-(2-(1H-Indol-3-yl)-1-(4-(4-methoxybenzyl)-5-phenethyl-4H-1,2,4-triazol-3-yl)ethyl)-2-aminoacetamide,3TBDMS,isomer #2COC1=CC=C(CN2C(CCC3=CC=CC=C3)=NN=C2C(CC2=CN([Si](C)(C)C(C)(C)C)C3=CC=CC=C23)NC(=O)CN([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C=C15376.5Semi standard non polar33892256
(R)-N-(2-(1H-Indol-3-yl)-1-(4-(4-methoxybenzyl)-5-phenethyl-4H-1,2,4-triazol-3-yl)ethyl)-2-aminoacetamide,3TBDMS,isomer #2COC1=CC=C(CN2C(CCC3=CC=CC=C3)=NN=C2C(CC2=CN([Si](C)(C)C(C)(C)C)C3=CC=CC=C23)NC(=O)CN([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C=C14521.9Standard non polar33892256
(R)-N-(2-(1H-Indol-3-yl)-1-(4-(4-methoxybenzyl)-5-phenethyl-4H-1,2,4-triazol-3-yl)ethyl)-2-aminoacetamide,3TBDMS,isomer #2COC1=CC=C(CN2C(CCC3=CC=CC=C3)=NN=C2C(CC2=CN([Si](C)(C)C(C)(C)C)C3=CC=CC=C23)NC(=O)CN([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C=C15546.3Standard polar33892256
(R)-N-(2-(1H-Indol-3-yl)-1-(4-(4-methoxybenzyl)-5-phenethyl-4H-1,2,4-triazol-3-yl)ethyl)-2-aminoacetamide,3TBDMS,isomer #3COC1=CC=C(CN2C(CCC3=CC=CC=C3)=NN=C2C(CC2=C[NH]C3=CC=CC=C23)N(C(=O)CN([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C=C15322.6Semi standard non polar33892256
(R)-N-(2-(1H-Indol-3-yl)-1-(4-(4-methoxybenzyl)-5-phenethyl-4H-1,2,4-triazol-3-yl)ethyl)-2-aminoacetamide,3TBDMS,isomer #3COC1=CC=C(CN2C(CCC3=CC=CC=C3)=NN=C2C(CC2=C[NH]C3=CC=CC=C23)N(C(=O)CN([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C=C14673.7Standard non polar33892256
(R)-N-(2-(1H-Indol-3-yl)-1-(4-(4-methoxybenzyl)-5-phenethyl-4H-1,2,4-triazol-3-yl)ethyl)-2-aminoacetamide,3TBDMS,isomer #3COC1=CC=C(CN2C(CCC3=CC=CC=C3)=NN=C2C(CC2=C[NH]C3=CC=CC=C23)N(C(=O)CN([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C=C15513.9Standard polar33892256
Spectra
Biological Properties
Cellular LocationsNot Available
Biospecimen Locations
  • Blood
Tissue LocationsNot Available
Pathways
Normal Concentrations
BiospecimenStatusValueAgeSexConditionReferenceDetails
BloodDetected but not QuantifiedNot QuantifiedNot SpecifiedNot SpecifiedNormal details
Abnormal Concentrations
Not Available
Associated Disorders and Diseases
Disease ReferencesNone
Associated OMIM IDsNone
DrugBank IDNot Available
Phenol Explorer Compound IDNot Available
FooDB IDNot Available
KNApSAcK IDNot Available
Chemspider ID68028142
KEGG Compound IDNot Available
BioCyc IDNot Available
BiGG IDNot Available
Wikipedia LinkNot Available
METLIN IDNot Available
PubChem Compound68741808
PDB IDNot Available
ChEBI IDNot Available
Food Biomarker OntologyNot Available
VMH IDNot Available
MarkerDB IDNot Available
Good Scents IDNot Available
References
Synthesis ReferenceNot Available
Material Safety Data Sheet (MSDS)Not Available
General References
  1. Barupal DK, Fiehn O: Generating the Blood Exposome Database Using a Comprehensive Text Mining and Database Fusion Approach. Environ Health Perspect. 2019 Sep;127(9):97008. doi: 10.1289/EHP4713. Epub 2019 Sep 26. [PubMed:31557052 ]